Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A in situ carcinoma that involves the nasopharynx.
Biomarker and diagnostic research for carcinoma in situ of nasopharynx has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
47 publications have been identified in PubMed for carcinoma in situ of nasopharynx. Research spans Basic Science / Preclinical (34%), Case Report / Case Series (32%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 16 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:09 PM UTC
Patient case studies | 15 | 32% |
Testing and diagnosis research | 6 | 13% |
Clinical study results | 3 | 6% |
New treatment approaches | 3 | 6% |
Research summaries | 2 | 4% |
Disease patterns and progression | 2 | 4% |
Cheng Y (2026). [PMID: 41342370](https://pubmed.ncbi.nlm.nih.gov/41342370/). *Cancer Res*. [Basic Science / Preclinical]
Yan Z (2026). [PMID: 41980669](https://pubmed.ncbi.nlm.nih.gov/41980669/). *Radiother Oncol*. [Clinical Trial Publication]
Shi M (2026). [PMID: 41208479](https://pubmed.ncbi.nlm.nih.gov/41208479/). *J Pathol*. [Basic Science / Preclinical]
Guo Q (2026). [PMID: 41358506](https://pubmed.ncbi.nlm.nih.gov/41358506/). *Head Neck*. [Diagnostic / Biomarker]
Tang Y (2026). [PMID: 41360030](https://pubmed.ncbi.nlm.nih.gov/41360030/). *Lung Cancer*. [Case Report / Case Series]
Jindal N (2026). [PMID: 42250259](https://pubmed.ncbi.nlm.nih.gov/42250259/). *Rev Med Virol*. [Review / Meta-Analysis]
Zhang X (2026). [PMID: 41547856](https://pubmed.ncbi.nlm.nih.gov/41547856/). *Nat Commun*. [Basic Science / Preclinical]
Lahiri A (2026). [PMID: 42163303](https://pubmed.ncbi.nlm.nih.gov/42163303/). *J Med Case Rep*. [Case Report / Case Series]
Xu Y (2026). [PMID: 42198896](https://pubmed.ncbi.nlm.nih.gov/42198896/). *J Med Virol*. [Diagnostic / Biomarker]
Liu Y (2026). [PMID: 41903631](https://pubmed.ncbi.nlm.nih.gov/41903631/). *Int J Biol Macromol*. [Basic Science / Preclinical]